Logo image of BCRX

BIOCRYST PHARMACEUTICALS INC (BCRX) Stock Analyst Ratings

NASDAQ:BCRX - Nasdaq - US09058V1035 - Common Stock - Currency: USD

8.76  -0.12 (-1.35%)

After market: 8.8 +0.04 (+0.46%)

Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to BCRX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 17.77. This target is 102.8% above the current price.
BCRX was analyzed by 18 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about BCRX.
In the previous month the buy percentage consensus was at a similar level.
BCRX was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.
BCRX Historical Analyst RatingsBCRX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -103 -93 -83 -73 -63 -53 -43 -33 -23 -13 -3 5 10 15

Price Target & Forecast

Price Low Median Mean High 8.7611.1116.8317.7731.50 - 26.83% 92.12% 102.80% 259.59%
BCRX Current Analyst RatingBCRX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10
Up and Down Grades
Date Firm Action Rating
2025-07-01 B of A Securities Maintains Buy -> Buy
2025-06-30 RBC Capital Reiterate Outperform -> Outperform
2025-06-30 Wedbush Maintains Outperform -> Outperform
2025-06-27 Needham Reiterate Buy -> Buy
2025-06-25 Needham Reiterate Buy -> Buy
2025-05-07 Barclays Maintains Equal-Weight -> Equal-Weight
2025-05-06 Needham Maintains Buy -> Buy
2025-05-06 RBC Capital Reiterate Outperform -> Outperform
2025-05-06 JP Morgan Maintains Overweight -> Overweight
2025-05-06 HC Wainwright & Co. Reiterate Buy -> Buy
2025-04-29 Cantor Fitzgerald Initiate Overweight
2025-04-11 RBC Capital Reiterate Outperform -> Outperform
2025-04-10 Needham Reiterate Buy -> Buy
2025-03-03 Citizens Capital Markets Reiterate Market Outperform -> Market Outperform
2025-02-25 Citizens Capital Markets Reiterate Market Outperform -> Market Outperform
2025-02-25 RBC Capital Reiterate Outperform -> Outperform
2025-02-25 HC Wainwright & Co. Reiterate Buy -> Buy
2025-01-31 JMP Securities Reiterate Market Outperform -> Market Outperform
2025-01-13 Needham Maintains Buy -> Buy
2025-01-13 Evercore ISI Group Maintains Outperform -> Outperform
2024-11-05 Needham Reiterate Buy -> Buy
2024-11-05 RBC Capital Reiterate Outperform -> Outperform
2024-11-05 Barclays Maintains Equal-Weight -> Equal-Weight
2024-08-06 JMP Securities Maintains Market Outperform -> Market Outperform
2024-08-06 RBC Capital Reiterate Outperform -> Outperform
2024-08-06 Barclays Maintains Equal-Weight -> Equal-Weight
2024-08-06 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-07 JMP Securities Maintains Market Outperform -> Market Outperform
2024-05-07 Needham Reiterate Buy -> Buy
2024-05-07 HC Wainwright & Co. Reiterate Buy -> Buy